Table 2.
Correlation between ATAD2 expression and clinicopathological features in papillary thyroid cancer (PTC) (n = 87)
| Characteristics | n | High expression (%) | Low expression (%) | P |
|---|---|---|---|---|
| Gender | ||||
| Male | 29 | 16 (55.2) | 13 (44.8) | 0.544 |
| Female | 58 | 28 (48.3) | 30 (51.7) | |
| Age (years) | ||||
| <45 | 48 | 23 (47.9) | 25 (52.1) | 0.582 |
| ≥45 | 39 | 21 (53.8) | 18 (46.2) | |
| Extrathyroidal extension | ||||
| Yes | 30 | 19 (63.3) | 11 (36.7) | 0.084 |
| No | 57 | 25 (43.9) | 32 (56.1) | |
| TNM staging | ||||
| I–II | 53 | 27 (50.9) | 26 (49.1) | 0.932 |
| III–IV | 34 | 17 (50.0) | 17 (50.0) | |
| Lymph node metastasis | ||||
| Yes | 63 | 34 (54.0) | 29 (46.0) | 0.305 |
| No | 24 | 10 (41.7) | 14 (58.3) | |
| Multicentricity | ||||
| Yes | 52 | 26 (50.0) | 26 (50.0) | 0.896 |
| No | 35 | 18 (51.4) | 17 (48.6) | |
| Tumor size (cm) | ||||
| <2 | 43 | 16 (37.2) | 27 (62.8) | 0.014* |
| ≥2 | 44 | 28 (63.6) | 16 (36.4) | |
*P < 0.05